Inclusion Criteria:

- All patients with Hodgkin's Lymphoma and Non Hodgkin's lymphoma who underwent RT to
either a mantle or modified mantle field with or without adriamycin at the Wilmot
Cancer Center at the University of Rochester are eligible for the study.

Exclusion Criteria:

- Any severe preexisting cardiac disease (e.g., arrhythmia, angina, coronary disease,
myocardial infarction, or congestive heart failure) prior to diagnosis